Smoking, health and ageing

被引：17

作者：

Nicita-Mauro V. ^{[1
]}

Basile G. ^{[1
]}

Maltese G. ^{[1
]}

Nicita-Mauro C. ^{[1
]}

Gangemi S. ^{[2
]}

Caruso C. ^{[3
]}

机构：

[1] Department of Geriatrics and Gerontology, University of Messina, Messina

[2] Department of Allergy and Clinical Immunology, University of Messina, Messina

[3] Immunosenescence Unit, University of Palermo, Palermo

来源：

Immunity & Ageing | / 5卷 / 1期

关键词：

Nicotine; Telomere Length; Nicotine Replacement Therapy; Varenicline; Nicotine Patch;

D O I：

10.1186/1742-4933-5-10

中图分类号：

学科分类号：

摘要：

On March 19, 2008 a Symposium on Pathophysiology of Ageing and Age-Related diseases was held in Palermo, Italy. Here, the lecture of V. Nicita-Mauro on Smoking, health and ageing is summarized. Smoking represents an important ageing accelerator, both directly by triggering an inflammatory responses, and indirectly by favoring the occurrence of several diseases where smoking is a recognized risk factor. Hence, non-smokers can delay the appearance of diseases and of ageing process, so attaining longevity. © 2008 Nicita-Mauro et al; licensee BioMed Central Ltd.

引用

共 26 条

[21]

Gourlay S.G., Benowitz N.L., The benefits of stopping smoking and the role of nicotine replacement therapy in older patients, Drugs Aging, 9, pp. 8-23, (1996)

[22]

Jorenby D.E., Leischow S.J., Nides M.A., Rennard S.I., Johnston J.A., Hughes A.R., Smith S.S., Muramoto M.L., Daughton D.M., Doan K., Fiore M.C., Baker T.B., A controlled trial of sustainedrelease bupropion, a nicotine patch, or both for smoking cessation, N Engl J Med, 340, pp. 685-691, (1999)

[23]

Tonstad S., Tonnesen P., Hajek P., William K.E., Billing C.B., Reeves K.R., Varenicline Phase 3 Study Group. Effect of maintenance therapy with varenicline on smoking cessation: A randomized controlled trial, JAMA, 296, pp. 64-71, (2006)

[24]

Jorenby D.E., Hays J.T., Rigotti N.A., Azoulay S., Watsky E.J., William K.E., Billing C.B., Gong J., Reeves K.R., Varenicline Phase 3 Study Group. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial, JAMA, 296, pp. 56-63, (2006)

[25]

Taylor Hays J., Ebbert J.O., Sood A., Efficacy and safety of varenicline for smoking cessation, AJM, 121, (2008)

[26]

Nides M., Update on pharmacological options for smoking cessation treatment, AJM, 121, (2008)

← 1 2 3 →